Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Dow
McKinsey
AstraZeneca
Mallinckrodt

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

Drug Price Trends for NDC 00002-3240

See Plans and Pricing

« Back to Dashboard

Average Pharmacy Cost for 00002-3240

Drug Name NDC Price/Unit ($) Unit Date
CYMBALTA 30 MG CAPSULE 00002-3240-30 8.02100 EACH 2019-02-19
CYMBALTA 30 MG CAPSULE 00002-3240-90 8.02100 EACH 2019-02-19
CYMBALTA 30 MG CAPSULE 00002-3240-30 7.71213 EACH 2018-12-19
CYMBALTA 30 MG CAPSULE 00002-3240-90 7.71213 EACH 2018-12-19
CYMBALTA 30 MG CAPSULE 00002-3240-30 7.59633 EACH 2018-11-21
CYMBALTA 30 MG CAPSULE 00002-3240-90 7.59633 EACH 2018-11-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 00002-3240

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
CYMBALTA 30MG CAP Eli Lilly & Company 00002-3240-30 30 163.26 5.44200 2018-08-01 - 2023-07-31 Big4
CYMBALTA 30MG CAP Eli Lilly & Company 00002-3240-30 30 159.06 5.30200 2019-01-01 - 2023-07-31 Big4
CYMBALTA 30MG CAPSULES Eli Lilly & Company 00002-3240-90 90 489.77 5.44189 2018-08-01 - 2023-07-31 Big4
CYMBALTA 30MG CAPSULES Eli Lilly & Company 00002-3240-90 90 478.05 5.31167 2019-01-01 - 2023-07-31 Big4
CYMBALTA 30MG CAP Eli Lilly & Company 00002-3240-30 30 238.49 7.94967 2019-01-01 - 2019-12-31 FSS
CYMBALTA 30MG CAPSULES Eli Lilly & Company 00002-3240-90 90 715.49 7.94989 2019-01-01 - 2019-12-31 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Express Scripts
Baxter
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.